Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Purpose Patients with intensively treated insulin-dependent diabetes mellitus (IDDM) exhibit more severe defects in counterregulatory hormone secretion and symptom recognition during hypoglycemia than do conventionally treated patients. In this prospective study in patients with preexisting defects in counterregulation, we examined the induction and reversibility of impaired symptomatic and adrenomedullary responses to hypoglycemia in 5 patients with IDDM (diabetes duration of 2 to 16 years; aged 19 to 36 years; 3 women, 2 men) who were receiving intensive therapy.Methods Counterregulatory responses were assessed by using a single-step (approximately 2.8 mmol/L plasma glucose) and multiple-step (from approximately 5 mmol/L to 2.2 mmol/L plasma glucose) clamped hypoglycemia procedure. Patients were first studied after a stable period of conventional insulin therapy (glycosylated hemoglobin [HbA1c] 9.5 +/- 1.2%), then after 3 to 5 months of intensive therapy (HbA1c 6.6 +/- 0.2%), and a third time after resuming conventional therapy (HbA1c 8.7 +/- 0.9%).Results Intensive therapy was associated with a 44% decline (P < 0.01) in the average plasma epinephrine increase during hypoglycemia, and the plasma glucose level required to stimulate epinephrine secretion fell from 3.7 +/- 0.2 to 3.0 +/- 0.1 mmol/L (P < 0.01). The threshold, but not the magnitude, of the plasma norepinephrine response was similarly altered. Hypoglycemic symptoms also decreased in intensity (by 67%, P < 0.01), and the glucose level required for symptom activation fell from 3.4 +/- 0.3 to 2.7 +/- 0.2 mmol/L, P < 0.01). When conventional therapy was resumed, the abnormalities in the epinephrine response due to intensive therapy were almost completely reversed. However, the reduction in symptoms and the altered thresholds for plasma norepinephrine were not reversed.Conclusions There is dissociation between the treatment-associated defects in hypoglycemia counterregulation in IDDM, and an increase in average glycemia produced by a return to conventional insulin therapy is not sufficient to reverse hypoglycemia unawareness worsened by intensive therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both hypoglycemia unawareness and defective glucose counterregulation are potentially reversible.”
From Hypoglycemia (2018) · cites this paper as [37]
In the citing paper
“Strict avoidance of hypoglycemia for a period of 2 days to 3 months has been associated with improvement in the recognition of severe hypoglycemia, the counterregulatory hormone responses or both (32)(33)(34)(35)(36)(37)(38)(39).”
From Hypoglycemia (2018) · cites this paper as [37]
Citations
Cites
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Mitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
(1987) · Diabetes Care · doi:10.2337/diacare.10.1.1 · Cited by 479
Fanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398
Schwartz, N. S., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112884 · Cited by 394
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
Amiel, S. A., Sherwin, R. S., Simonson, D. C., & Tamborlane, W. V. (1988) · Diabetes · doi:10.2337/diab.37.7.901 · Cited by 393
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
Cryer, P. E. (1992) · Diabetes · doi:10.2337/diab.41.3.255 · Cited by 231
Cited by
Islet Transplantation as a Treatment for Diabetes — A Work in Progress
Robertson, R. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032425 · Cited by 434
Symptoms of hypoglycaemia in people with diabetes
McAulay, V., Deary, I. J., & Frier, B. M. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00620.x · Cited by 264
Yeoh, E., Choudhary, P., Nwokolo, M., Ayis, S., & Amiel, S. A. (2015) · Diabetes Care · doi:10.2337/dc15-0102 · Cited by 154
Drug-Induced Disorders of Glucose Metabolism: Mechanisms and Management
Chan, J. C. N., Cockram, C. S., & Critchley, J. (1996) · Drug Safety · doi:10.2165/00002018-199615020-00005 · Cited by 122
Interactions between hypoglycemia and sleep architecture in children with type 1 diabetes mellitus
Pillar, G., Schuscheim, G., Weiss, R., Malhotra, A., McCowen, K. C., Shlitner, A., Peled, N., & Shehadeh, N. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.66 · Cited by 118
Metadata
- Authors
- Davis, M., Mellman, M., Friedman, S., Chang, C. J., & Shamoon, H.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1994-12
- Volume
- 97
- Issue
- 6
- Pages
- 535-542
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2081906000
- Cited by
- 33
- References
- 25
- Citations by year
- 2023: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 5 · 2012: 2
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institute of Diabetes and Digestive and Kidney Diseases (DK0700419, DK20541)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, intensive insulin therapy, hypoglycemia counterregulation, epinephrine response, hypoglycemic symptoms, norepinephrine, glycemic variability, conventional insulin therapy, HbA1c, autonomic dysfunction
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Epinephrine, Female, Humans, Hydrocortisone, Hypoglycemia, Insulin, Male, Norepinephrine, Prospective Studies, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. https://app.cochat.ai/papers/10.1016/0002-9343(94)90349-2
- The paper
- Davis, M., Mellman, M., Friedman, S., Chang, C. J., & Shamoon, H. (1994). Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(94)90349-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.